Pfizer Lilly: Different Bets on Pharma M&A Explained
Eli Lilly posts a blockbuster start to 2026 as Pfizer works to rebuild after the COVID era, highlighting pfizer lilly...
Uncover creative ways to make extra money through hobbies and turn your passions into profitable ventures. Start monetizing your interests today.
24,233 articlesEli Lilly posts a blockbuster start to 2026 as Pfizer works to rebuild after the COVID era, highlighting pfizer lilly...
A veteran wealth manager makes a bold move into defense stocks as geopolitical tensions rise. Learn the strategy, ris...
A federal policy shift has just opened new doors for cannabis operators. For Green Thumb Industries and its investors...
A clear, practical breakdown of DEFT's Q4 2025 results and what the deft 2025 earnings transcript signals for 2026. L...
Long-term holders in NVDA, AMD, and LLY are posting outsized gains as AI and GLP-1 drug momentum persists. Traders wh...
When Berkshire Hathaway named Greg Abel to lead investments, the portfolio made a surprising pivot. This article brea...
BNB Chain rolls out the Agent Survival Pack, letting autonomous AI agents cover their own operating costs on-chain vi...
CFO Mandy Fields shifts to lead e.l.f. Beauty's AI strategy, anchoring governance, commerce readiness and efficiency ...
A major move in the ETF world: Security Financial Services opens a substantial CORO stake. This article breaks down w...
The latest Beige Book shows inflation pressing higher in most districts, led by energy costs and shipping pressures. ...
NVIDIA just slipped below a historic milestone, reigniting the debate about who could realistically challenge its AI ...
Gulf sovereign funds are expanding AI bets, backing SpaceX-linked ventures and major AI rounds, signaling a shift fro...